Methods and compositions for treating an angiotensinogen- (agt-) associated disorder
US-2024247266-A1 · Jul 25, 2024 · US
Lin Kang is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lin Kang |
| Total patents | 12 |
| First publication | May 16, 2017 |
| Latest publication | Jul 25, 2024 |
Publications ranked by popularity score, then publication date.
US-2024247266-A1 · Jul 25, 2024 · US
US-11522324-B2 · Dec 6, 2022 · US
US-11476579-B2 · Oct 18, 2022 · US
US-2022247138-A1 · Aug 4, 2022 · US
US-2022052453-A1 · Feb 17, 2022 · US
US-10897653-B2 · Jan 19, 2021 · US
US-D856290-S · Aug 13, 2019 · US
US-10312607-B2 · Jun 4, 2019 · US
US-2019166406-A1 · May 30, 2019 · US
US-2019103686-A1 · Apr 4, 2019 · US
Latest publications not already listed above.
US-2019074904-A1 · Mar 7, 2019 · US
US-9654062-B2 · May 16, 2017 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pct int inc | 11 |
| Alnylam Pharmaceuticals Inc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| H04N7/104 | 5 |
| H03F3/189 | 3 |
| H04N21/6118 | 2 |
| H04N21/6168 | 2 |
| H04N5/38 | 2 |